SYS-CON MEDIA Authors: Gilad Parann-Nissany, Unitiv Blog, Kevin Benedict, Maxime Charlès, RealWire News Distribution

News Feed Item

Global Atrial Fibrillation Market Report 2013 - 2019

DUBLIN, December 23, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/jnp98l/atrial) have announced the addition of the "Global Atrial Fibrillation Market Report 2013 - 2019" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Atrial fibrillation is a type of cardiac arrhythmia identified by an abnormal cardiac rhythm caused by a disturbance in the heart's electrical system. Atrial fibrillation (AF) is one of the most commonly occurring cardiac rhythm conditions. As a potentially life-threatening disease and a condition that's expensive to treat, the healthcare system views treatment for this condition as a strategically critical area to address. This report analyzes the market for atrial fibrillation from the point of view of various pharmacological and non-pharmacological treatment products.

The pharmacological AF treatment market has been further classified into the specific drugs commonly used for treating AF, namely anti-arrythmics and anti-coagulants. The non-pharmacological atrial fibrillation devices market has been further sub-divided into therapeutic procedures such as catheter ablation procedures, maze surgery and electric cardioversion. The major methods of catheter ablation procedures studied in this report include radiofrequency, high intensity focused ultrasound (HIFU), cryoablation, microwave ablation and laser catheter ablation.

Key Topics Covered:

1 Preface
1.1 Report description
1.2 Market segmentation
1.3 Research methodology

2 Executive Summary

3 Market Overview
3.1 Introduction
3.2 Market Dynamics
3.3 Porter's Five Forces Analysis for the Global Atrial Fibrillation Market

4 Atrial Fibrillation Market, by Treatment Types
4.1 Overview
4.2 Global Pharmacological Treatments for Atrial Fibrillation Market
4.3 Non-Pharmacological Treatment for Atrial Fibrillation Market

5 Atrial Fibrillation Market, by Geography
5.1 Overview
5.2 North America
5.3 Europe
5.4 Asia-Pacific
5.5 Rest of the World (RoW)

6 Competitive Landscape

7 Recommendations
7.1 Investing in emerging markets, particularly China and Brazil
7.2 Focus on emerging technologies such as mini-maze procedure and catheter ablation

8 Company Profiles

Companies Mentioned:

  • AtriCure, Inc
  • Biosense Webster, Inc
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Corporation
  • CardioFocus, Inc
  • Endoscopic Technologies, Inc
  • Johnson and Johnson Ltd
  • Sanofi Aventis
  • St Jude Medical, Inc

For more information visit http://www.researchandmarkets.com/research/jnp98l/atrial

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.